Episodes
-
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
-
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts discuss the latest evidence and clinical implications of recently approved treatments for relapsed/refractory follicular lymphoma (R/R FL), the importance of shared decision-making in treatment selection in the era of BsAb and CAR T-cell therapies, and the key considerations for treatment sequencing.
The experts
Dr Matthew Lunning, University of Nebraska, Omaha, NE, USA,Professor Charalambos Andreadis, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA,Dr Tara Graff, Mission Cancer and Blood, Des Moines, IA, USA.This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb and is jointly provided by USF Health and touchIME.
For further information visit: https://touchhaematologyime.org/evolving-treatment-paradigm-relapsed-refractory-follicular-lymphoma
-
Missing episodes?
-
touchEXPERT OPINIONS for touchINFECTIOUS DISEASES
Listen to leading experts describe the HIV life cycle, the rationale for multidrug antiretroviral therapy (ART) regimens, mechanisms of ART resistance and how to manage it in people living with HIV.
The experts
Prof. Anne-Mieke Vandamme - Katholieke Universiteit Leuven, BelgiumProf. José Arribas - La Paz Hospital, Madrid, SpainProf. Antonella Castagna - Vita-Salute San Raffaele University, Milan, ItalyThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is provided by touchIME.
For further information visit our website:
https://touchinfectiousdiseases.com/
-
touchIN CONVERSATION for touchRESPIRATORY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.
The experts
Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, SpainProf. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UKThis touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchrespiratoryime.org/her2_nsclc_testing_and_targeted_therapies/
-
touchIN CONVERSATION for touchONCOLOGY
Listen to a medical oncologist and a pathologist as they discuss HER2 alterations in non-small cell lung cancer (NSCLC), including the different types of HER2 alterations, key considerations for HER2 testing and the latest data for HER2-targeting treatments.
The experts
Prof. Enriqueta Felip - Medical Oncologist, Vall d'Hebron University Hospital, Barcelona, SpainProf. Keith Kerr - Aberdeen University Medical School and Aberdeen Royal Infirmary, Aberdeen, UKThis touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca, and is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/her2_nsclc_testing_and_targeted_therapies/
-
touchIN CONVERSATION for touchNEUROLOGY - Early diagnosis and treatment of NMOSD: Practical insights
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
Prof. John Chen - Mayo Clinic, Rochester, MN, USAProf. Friedemann Paul - Charité - Universitätsmedizin Berlin, Campus Mitte, GermanyThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchneurologyime.org/nmosd_diagnosis_treatmenthttps://touchneurologyime.org/nmosd_diagnosis_treatment
-
touchIN CONVERSATION for touchOPTHAMOLOGY
Listen to a neurologist and a neuro-ophthalmologist, both renowned experts in neuromyelitis optica spectrum disorder (NMOSD), answer questions from the ophthalmology and neurology communities on the management of NMOSD. They discuss presenting symptoms, differential diagnoses, management of acute attacks and long-term treatment.
The experts:
Prof. John Chen - Mayo Clinic, Rochester, MN, USAProf. Friedemann Paul - Charité - Universitätsmedizin Berlin, GermanyThis touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Horizon Therapeutics. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchophthalmologyime.org/nmosd_diagnosis_treatmenthttps://touchneurologyime.org/nmosd_diagnosis_treatment
-
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPaediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USAThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPathologist: Dr Eric Gars, Gainesville, FL, USAThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME
-
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPaediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USACritical care pharmacist: Prof. Rob MacLaren, Denver, COThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchMDT for touchHAEMATOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPaediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USAThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the clinical features of HLH in patients and when it is important to have a high index of suspicion of HLH.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPaediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USAThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist and a pathologist discuss the role of the pathologist in the diagnostic workup of patients suspected of having HLH, including the insights available from bone marrow biopsy in identifying triggers for HLH.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPathologist: Dr Eric Gars, Gainesville, FL, USAThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist, paediatric intensivist and critical care pharmacist discuss the importance of an individualized approach to the treatment of HLH, particularly when considering the age of the patient.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPaediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USACritical care pharmacist: Prof. Rob MacLaren, Denver, COThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchMDT for touchIMMUNOLOGY
Listen to an HLH specialist and a paediatric intensivist discuss the standard of care for patients with primary HLH and highlight the introduction of novel agents for second-line therapy for patients who do not respond in the first line.
The multidisciplinary team
HLH specialist: Prof. Michael Jordan, Cincinnati, OH, USAPaediatric intensivist: Dr Kate Kernan, Pittsburgh, PA, USAThis touchPODCAST is for healthcare professionals in the USA only.
This activity is funded by an unrestricted independent medical education grant from Sobi Inc. This activity is jointly provided by USF Health and touchIME.
-
touchIN CONVERSATION for touchNEUROLOGY
Listen to Dr Carolyn Clevenger, a gerontological nurse practitioner, in conversation with family care partner Ms Kathleen Rhyne. They respond to questions submitted by the HCP audience, providing valuable insights on agitation in Alzheimer’s dementia with a focus on prevalence, behavioural symptoms and the importance of early recognition and diagnosis.
This touchPODCAST is for healthcare professionals outside of the UK only.
This activity is funded by an unrestricted independent medical education grant from Lundbeck. This activity is jointly provided by USF Health and touchIME in collaboration with the Gerontological Society of America (GSA).
For further information visit our website: https://touchneurology.com/education/mdt-perspectives-on-management-of-agitation-in-alzheimers-dementia/in-conversation-lets-talk-about-AAD/
-
touchPANEL DISCUSSION for touchONCOLOGY
Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
Prof. Dr Vito Sabato, University of Antwerp, Antwerp, BelgiumDr Sigurd Broesby-Olsen, Odense University Hospital, Odense, DenmarkProf. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USAThis touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit: https://touchoncologyime.org/mdt-insights-systemic-mastocytosis
-
touchPANEL DISCUSSION for touchHAEMATOLOGY
Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
Prof. Dr Vito Sabato, University of Antwerp, Antwerp, BelgiumDr Sigurd Broesby-Olsen, Odense University Hospital, Odense, DenmarkProf. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USAThis touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit: https://touchhaematologyime.org/mdt-insights-systemic-mastocytosis
-
touchPANEL DISCUSSION for touchDERMATOLOGY
Listen to a panel of leading experts—a renowned allergist, dermatologist, and haemato-oncologist—discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
Prof. Dr Vito Sabato, University of Antwerp, Antwerp, BelgiumDr Sigurd Broesby-Olsen, Odense University Hospital, Odense, DenmarkProf. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USAThis touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit: https://touchdermaime.org/mdt-insights-systemic-mastocytosis
-
touchPANEL DISCUSSION for touchIMMUNOLOGY
Listen to a panel of leading experts a renowned allergist, dermatologist, and haemato-oncologist discuss the diagnosis and management of systemic mastocytosis, including current and emerging treatment options and multidisciplinary approaches to optimize patient care.
The experts
Prof. Dr Vito Sabato, University of Antwerp, Antwerp, BelgiumDr Sigurd Broesby-Olsen, Odense University Hospital, Odense, DenmarkProf. Prithviraj Bose, MD Anderson Cancer Center University of Texas, TX, USAThis touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Blueprint Medicines and is jointly provided by USF Health and touchIME.
For further information visit: https://touchimmunologyime.org/mdt-insights-systemic-mastocytosis
- Show more
